Cantos
P&O -- Video Interviews with CEO and CFO
March 08, 2005 02:22 ET | Cantos
LONDON, March 8, 2005 (PRIMEZONE) -- P&O -- preliminary results 2004 Indepth interviews available now on www.cantos.com with Robert Woods, CEO and Nick Luff, CFO (LSE:PO). -- Results and...
Telenor 150 år - gir
Telenor 150 år - gir jubileumsgave til skolen
March 08, 2005 02:11 ET | Telenor
"En god skole og et høyt kunnskapsnivå er avgjørende for samfunns- og næringsutviklingen. Telenor ønsker å bidra til at norsk skole får et kraftig løft på et område der selskapet har spesiell...
nokialogo.png
Mobile TV pilot begins in Finland
March 08, 2005 01:56 ET | Nokia Oyj
Brings live television broadcasts to mobile devices   Espoo, Finland - On 8 March 2005, Digita, Elisa, MTV, Nelonen, Nokia, Sonera and YLE (The Finnish Broadcasting Company) are starting a...
nokialogo.png
Mobiili-tv -pilotti käynnistyy Suomessa
March 08, 2005 01:55 ET | Nokia Oyj
Televisiolähetykset reaaliajassa matkapuhelimiin   Digita, Elisa, MTV, Nelonen, Nokia, Sonera ja YLE aloittavat kansainvälisesti ainutlaatuisen mobiili-tv -pilotin 8. maaliskuuta Suomessa....
Basilea Investigates Novel Antibiotic Class with Potential to Treat Acne and Rosacea
March 08, 2005 01:30 ET | Basilea Pharmaceutica Ltd
BASEL, Switzerland, March 8, 2005 (PRIMEZONE) -- Basilea Pharmaceutica AG announced the advancement of the novel topical antibiotic BAL19403 into preclinical testing. BAL19403 is the most advanced of...
Basilea-Logo.jpg
Basilea Investigates Novel Antibiotic Class with Potential to Treat Acne and Rosacea
March 08, 2005 01:15 ET | Basilea Pharmaceutica AG
Basel, Switzerland, 8 March 2005   Basilea Pharmaceutica AG announced the advancement of the novel topical antibiotic BAL19403 into preclinical testing. BAL19403 is the most advanced of a new...
Basilea-Logo.jpg
Basilea Prüft Neue Antibiotika Klasse für die Behandlung von Akne und Rosacea
March 08, 2005 01:15 ET | Basilea Pharmaceutica AG
Basel, 8. März 2005   Basilea Pharmaceutica AG gab den Beginn der präklinischen Prüfung eines neuen antibakteriellen Wirkstoffs, BAL19403, bekannt. BAL19403 ist die am weitesten...
Aspo_Logo_RGB.png
INVITATION TO THE ASPO ANNUAL SHAREHOLDERS' MEETING
March 08, 2005 01:01 ET | Aspo Plc
The shareholders of Aspo Plc are invited to attend the Annual Shareholders' Meeting to be held on Thursday, 31 March 2005 at 4:00 p.m. at Hotel Palace, conference hall, Eteläranta 10, FI-00130...
Aspo_Logo_RGB.png
KUTSU ASPON VARSINAISEEN YHTIÖKOKOUKSEEN
March 08, 2005 01:01 ET | Aspo Plc
Aspo Oyj:n osakkeenomistajat kutsutaan varsinaiseen yhtiökokoukseen, joka pidetään torstaina maaliskuun 31. päivänä 2005 klo 16.00 alkaen Hotel Palacen Konferenssisalissa, Eteläranta 10, 00130...
sika_mainlogo.jpg
Sika auf Kurs
March 07, 2005 23:00 ET | Sika AG
Der Sika-Konzern erreichte im Jahr 2004 mit CHF 2 559.8 Mio. ein Nettoerlöswachstum von 12.9%. Davon waren 2.1% akquisitions- und devestitionsbedingt.   Im Vergleich zum Vorjahr nahm der...